NHI officer exercises options, holds 32,122 shares

National Health Investors (NHI) senior vice president and chief accounting officer Travis David L exercised multiple stock options on February 9, 2026, acquiring common shares through option exercises at exercise prices of $53.41 and $54.73 per share.

Accepted by SEC EDGAR 02/11/2026 - 04:34 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

National Health Investors (NHI) senior vice president and chief accounting officer Travis David L exercised multiple stock options on February 9, 2026, acquiring common shares through option exercises at exercise prices of $53.41 and $54.73 per share.

Following these exercises, a separate transaction used 28,868 common shares at $85.10 in a tax-withholding disposition, leaving him with 32,122 shares of NHI common stock held directly after all reported transactions.

Insider Trade Summary

37,200 shares exercised/converted

Exercise 11 txns

Insider Travis David L

Role SVP/Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to buy) 2022	2,404	$0.00	$0.00
Exercise	Stock Option (Right to buy) 2022	9,796	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2023	8,333	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2023	8,333	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2023	8,334	$0.00	$0.00
Exercise	Common Stock	2,404	$53.41	$128K
Exercise	Common Stock	9,796	$53.41	$523K
Exercise	Common Stock	8,333	$54.73	$456K
Exercise	Common Stock	8,333	$54.73	$456K
Exercise	Common Stock	8,334	$54.73	$456K
Exercise Price or Tax Liability	Common Stock	28,868	$85.10	$2.46M

Holdings After Transaction: Stock Option (Right to buy) 2022 — 0 contracts (Direct); Stock Option (Right to Buy) 2023 — 0 contracts (Direct); Common Stock — 32,122 shares (Direct)

Holdings Before and After: Stock Option (Right to buy) 2022, 12,200 to 0 contracts (Direct); Stock Option (Right to Buy) 2023, 25,000 to 0 contracts (Direct); Common Stock, 23,790 to 32,122 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did NHI officer Travis David L report on this Form 4?

He reported exercising several stock options into NHI common shares and then using 28,868 shares for a tax-withholding disposition. After these transactions, he directly held 32,122 shares of NHI common stock as of the reported date.

How many NHI common shares did the officer hold after the reported Form 4 transactions?

After completing all reported transactions, including option exercises and a tax-withholding disposition, the NHI senior vice president and chief accounting officer directly owned 32,122 shares of NHI common stock, according to the beneficial ownership column in the non-derivative securities table.

What was the nature of the stock option activity reported by NHI insider Travis David L?

The filing shows exercises of multiple stock option grants from 2022 and 2023 into NHI common stock. Each option exercise is coded "M," indicating derivative exercises or conversions, with the derivative positions reduced to zero after conversion into common shares.

What does the F-coded transaction in the NHI Form 4 represent?

The F-coded transaction represents a tax-withholding disposition. The filing states this code is for payment of exercise price or tax liability by delivering securities, involving 28,868 NHI common shares at $85.10, reducing post-transaction direct holdings to 32,122 shares.

Who is the reporting person on this NHI Form 4 and what is their role?

The reporting person is Travis David L, identified as an officer of National Health Investors Inc. His title is senior vice president and chief accounting officer, and he is not listed as a director or 10% owner in the relationship section.

On what date did the NHI insider transactions reported on this Form 4 occur?

All reported transactions occurred on February 9, 2026. Both the exercises of stock options and the related tax-withholding disposition in NHI common stock share the same transaction date in the tables summarizing non-derivative and derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Travis David L

(Last)

(First)

(Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO

37129

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP/Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/09/2026		M		2,404	A	$53.41	26,194	D
Common Stock	02/09/2026		M		9,796	A	$53.41	35,990	D
Common Stock	02/09/2026		M		8,333	A	$54.73	44,323	D
Common Stock	02/09/2026		M		8,333	A	$54.73	52,656	D
Common Stock	02/09/2026		M		8,334	A	$54.73	60,990	D
Common Stock	02/09/2026		F		28,868	D	$85.1	32,122	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to buy) 2022	$53.41	02/09/2026		M			2,404	02/25/2023	02/25/2027	Common Stock	2,404	$0	0	D
Stock Option (Right to buy) 2022	$53.41	02/09/2026		M			9,796	02/25/2024	02/25/2027	Common Stock	9,796	$0	0	D
Stock Option (Right to Buy) 2023	$54.73	02/09/2026		M			8,333	02/24/2023	02/24/2028	Common Stock	8,333	$0	0	D
Stock Option (Right to Buy) 2023	$54.73	02/09/2026		M			8,333	02/24/2024	02/24/2028	Common Stock	8,333	$0	0	D
Stock Option (Right to Buy) 2023	$54.73	02/09/2026		M			8,334	02/24/2025	02/28/2028	Common Stock	8,334	$0	0	D

Explanation of Responses:

	/s/ Kimberly V. Ouimet, by limited power of attorney	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR